This post was contributed by a community member. The views expressed here are the author's own.

Health & Fitness

A Safe & Accurate Early Detection Cancer Test

Cancer is the second leading cause of death, killing more than half a million people a year.

Cancer is a big business. The cancer drug industry alone brings in $100 billion a year.

One of the greatest tools in battling cancer is early detection. Early detection dramatically increases the possibility of a permanent cure. The problem with many forms of early detection is that they involve radiation exposure, which can increase the chance of getting cancer, which is the exact thing that you would be trying to avoid. The only truly safe level of radiation exposure is zero.

There is a little known test called the AMAS test, or the Anti-Malignan Antibody Serum test. The AMAS test is remarkably useful for cancer screening and treatment monitoring. It is safe, relatively inexpensive and over 95% accurate.

Find out what's happening in Ramseyfor free with the latest updates from Patch.

The AMAS test was developed by neurochemist Samuel Bogoch, M.D., Ph.D., who said that the AMAS test “definitively determines whether or not cancer is present” by testing for anti-malignin antibodies, which are produced by all cancers.

How the AMAS Test Works:

Find out what's happening in Ramseyfor free with the latest updates from Patch.

The AMAS test is a blood test. There is an antigenic protein on the surface of cancer cells. Dr. Bogoch named them “malignin”. When our immune system identifies the presence of malignin, it starts making anti-malignin antibodies. The AMAS test accurately detects all types of early cancer.

The AMAS test is positive if any type of cancer exists anywhere in the body. The AMAS test is very accurate. False positives run about 5% and false negatives about 7%. If repeated, test accuracy improves to over 99%, with false positive and false negative rates dropping to less than 1%.

An AMAS test score goes down with successful cancer treatment. Normal AMAS levels in successfully treated cancer patients indicate absence of malignancy.

The price of the actual test costs around $165.00, not including doctor’s office fees and shipping charges.

Our bodies are constantly producing and destroying cancer cells, meaning anti-malignin antibodies are present at low levels in everyone, all of the time. A healthy immune system actively destroys cancer cells before they can become a tumor. Cancer is a part of life and cancer patients need to understand that what has happened in their case is that their immune system failed to work as it should have.

A weakened immune system may allow cancer cells to replicate out of control, resulting in an AMAS level that will rise beyond the baseline of 135, indicating that the immune system is not working sufficiently enough, which results in cancer growth.

The cutoff point for a positive AMAS is 135. Patients with active cancer have AMAS levels above 135. AMAS levels below 135 are seen in individuals who do not have active cancer.

Aside from screening for cancer, AMAS can also monitor for the presence of cancer during treatment and therefore monitor the effectiveness of any cancer treatment.

The drawback of the AMAS test is that it is a screening. It is unable to detect the type of cancer or location of the cancer in the body. Additional testing is then needed to obtain that information.

A huge benefit of the AMAS test is that the higher the test result is over 135, the more widespread the cancer may be. When future test results go up, the cancer is worsening. When future test results go down, the cancer is improving. Another huge benefit is that this test protects healthy cells and tissues.

Broad-based studies on AMAS have found that dozens of researchers and medical centers have “conclusively demonstrated the value” of the test as a screening method for early cancer detection.

The AMAS test is now paid for by Medicare. Medicare does not generally pay for any procedure that is considered experimental or investigational. Other major insurance companies will hopefully follow Medicare’s lead and start paying for the AMAS test too.

If the AMAS test is covered by your insurance company or not, it is a bargain next to many other cancer screenings. Test results are available to your doctor in 3 - 5 business days.

Not only can the AMAS test detect cancer at extremely low levels, but it can do so without harmful radiation. AMAS can identify breast cancer as small as a pencil dot.

The only lab in the world that offers the AMAS test is Oncolab in Boston. To make sure that the test is accurate, the blood sample has to be shipped overnight to the lab in a container with 3 pounds of dry ice.

The AMAS test is not offered by the majority of doctors. If you would like more information about the AMAS test, or of you would like me to arrange for you to be tested, please contact me.

Read More

The views expressed in this post are the author's own. Want to post on Patch?

More from Ramsey